Conmy Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Terazosin HCl

Indications/Uses

HTN & symptomatic benign prostatic hyperplasia (BPH).

Click to view Conmy detailed prescribing information

Dosage/Direction for Use

BPH Initially 1 mg at bedtime, subsequently increase stepwise to 2, 5 or 10 mg once daily at 7 days intervals. HTN Initially 1 mg at bedtime increasing gradually at 7 days intervals according to patient's response, up to 20 mg daily. Usual maintenance dose: 2-10 mg daily.

Click to view Conmy detailed prescribing information

Overdosage

View Conmy overdosage for action to be taken in the event of an overdose.

Administration

May be taken with or without food.

Contraindications

Hypersensitivity. Not for treatment of heart failure caused by mechanical obstruction ie, aortic or mitral valve stenosis, pulmonary embolism & restrictive pericardial disease.

Click to view Conmy detailed prescribing information

Warnings

For additional cautionary notes to warn of the potential risk of using the medicine... Click to view Conmy detailed prescribing information

Special Precautions

Postural hypotension & syncope in association w/ the 1st dose or 1st few days of therapy. Patients w/ BPH should be examined prior to start of therapy to rule out the presence of prostate carcinoma. May impair ability to drive or operate machinery. Pregnancy & lactation. Childn.

Click to view Conmy detailed prescribing information

Use In Pregnancy & Lactation

Click to view Conmy detailed prescribing information

Adverse Reactions

Dizziness, lightheadedness, palpitations; hypotension, postural hypotension, syncope, vertigo.

Click to view Conmy detailed prescribing information

Drug Interactions

Possibility of developing significant hypotension w/ verapamil & other antihypertensives.

Click to view Conmy detailed prescribing information

Storage

View Conmy storage conditions for details to ensure optimal shelf-life.

Description

View Conmy description for details of the chemical structure and excipients (inactive components).

Action

View Conmy mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Drugs for Bladder & Prostate Disorders / Other Antihypertensives

ATC Classification

G04CA03 - terazosin ; Belongs to the class of alpha-adrenoreceptor antagonists. Used in the treatment of benign prostatic hypertrophy.

Regulatory Classification

Presentation/Packing

Form

Conmy tab 2 mg

Packing/Price

100's

Conmy

terazosin

Manufacturer:

Taiwan Biotech

Distributor:

New Smart Formulae